Dimed S.A. Distribuidora de Medicamentos

BOVESPA:PNVL3 Stock Report

Market Cap: R$1.2b

Dimed Distribuidora de Medicamentos Dividends and Buybacks

Dividend criteria checks 5/6

Dimed Distribuidora de Medicamentos is a dividend paying company with a current yield of 3.09% that is well covered by earnings. Next payment date is on 31st March, 2025 with an ex-dividend date of 8th April, 2024.

Key information

3.1%

Dividend yield

-0.2%

Buyback Yield

Total Shareholder Yield2.9%
Future Dividend Yield7.6%
Dividend Growth7.4%
Next dividend pay date31 Mar 25
Ex dividend date08 Apr 24
Dividend per shareR$0.252
Payout ratio17%

Recent dividend and buyback updates

Recent updates

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

Nov 04
Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Jul 12
These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

May 27
Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Apr 15
Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

Mar 25
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Jan 06
The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Oct 23
Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Aug 15
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: PNVL3's dividends per share have been stable in the past 10 years.

Growing Dividend: PNVL3's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Dimed Distribuidora de Medicamentos Dividend Yield vs Market
How does PNVL3 dividend yield compare to the market?
SegmentDividend Yield
Company (PNVL3)3.1%
Market Bottom 25% (BR)3.1%
Market Top 25% (BR)9.9%
Industry Average (Consumer Retailing)1.7%
Analyst forecast (PNVL3) (up to 3 years)7.6%

Notable Dividend: PNVL3's dividend (3.09%) is higher than the bottom 25% of dividend payers in the BR market (3.07%).

High Dividend: PNVL3's dividend (3.09%) is low compared to the top 25% of dividend payers in the BR market (9.92%).


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (17%), PNVL3's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (30.2%), PNVL3's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 14:29
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dimed S.A. Distribuidora de Medicamentos is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Frederico MendesBradesco S.A. Corretora de Títulos e Valores Mobiliários
Marcio OsakoBradesco S.A. Corretora de Títulos e Valores Mobiliários
Francisco NavarreteBradesco S.A. Corretora de Títulos e Valores Mobiliários